
pmid: 15304343
We have identified a new guanine‐nucleotide exchange factor, P‐Rex2, and cloned it from human skeletal muscle and brain libraries. It has widespread tissue distribution but is not expressed in neutrophils. P‐Rex2 is a 183 kDa protein that activates the small GTPase Rac and is regulated by phosphatidylinositol (3,4,5)‐trisphosphate and the βγ subunits of heterotrimeric G proteins in vitro and in vivo. P‐Rex2 has structure, activity and regulatory properties similar to P‐Rex1 but has divergent tissue distribution, as P‐Rex1 is mainly expressed in neutrophils. Together, they form an enzyme family capable of mediating Rac signalling downstream of G protein‐coupled receptors and phosphoinositide 3‐kinase.
P-Rex2, P-Rex1, Inositol 1,4,5-Trisphosphate, Blotting, Northern, PI3K, Heterotrimeric GTP-Binding Proteins, Recombinant Proteins, Rac, rac GTP-Binding Proteins, Protein Subunits, Organ Specificity, Humans, GEF, Cloning, Molecular, Gβγ subunits, Gene Library
P-Rex2, P-Rex1, Inositol 1,4,5-Trisphosphate, Blotting, Northern, PI3K, Heterotrimeric GTP-Binding Proteins, Recombinant Proteins, Rac, rac GTP-Binding Proteins, Protein Subunits, Organ Specificity, Humans, GEF, Cloning, Molecular, Gβγ subunits, Gene Library
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 106 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
